NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for EvoGenix Ltd


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Study results from I. Koukoulas and colleagues broaden understanding of DNA research
2008 MAR 31 ... 2008;53(1):135-141). For additional information, contact I. Koukoulas, EvoGenix Ltd, 343 Royal Parade, Parkville, Vic 3052, Australia. Publisher contact ...
Subject: DNA Research
Price: $3.00
*
AVEO Pharmaceuticals to Utilize Peptech's Breakthrough Technology to ''Humanise'' Internal Drug Candidates
2007 OCT 15 ... This is the first commercial deal Peptech (through its wholly-owned subsidiary, EvoGenix) has signed for its Superhumanisation(TM) technology which it obtained through its ...
Subject: Bioengineering
Price: $3.00
*
EvoGenix to Commence Second Project with GlaxoSmithKline
2007 AUG 27 ... Pre-Trials Research, Protein Design, Protein Engineering, Protein Therapies, Proteomics, EvoGenix Ltd. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bioengineering
Price: $3.00
*
New reports from InNexus Biotechnology detailed
2007 JUL 30 ... viral infections. InNexus will work with antibody therapeutic company EvoGenix, Ltd., (EGX), which is developing an improved version of the antiviral drug for clinical ...
Subject: InNexus Biotechnology
Price: $3.00
*
Officials from EvoGenix report on recent activities
2007 MAY 22 ... news developments at EvoGenix. Report 1: Antibody therapeutics company EvoGenix Ltd (EGX) announced that it has been awarded a patent by the U.S. Patent Office (patent ...
Subject: EvoGenix
Price: $3.00
*
EvoGenix officials summarized the newest activities
2007 APR 10 ... news developments at EvoGenix. Report 1: Antibody therapeutics company EvoGenix Ltd (EGX) announced that it has been awarded a patent by the U.S. Patent Office (patent ...
Subject: EvoGenix
Price: $3.00
*
EvoGenix Achieves Milestone in Collaboration with GlaxoSmithKline
2007 APR 9 ... Marketing and Licensing Agreements, Pharmaceutical Business, Pharmaceutical Company, EvoGenix Ltd. This article was prepared by Biotech Business Week editors from staff ...
Subject: Marketing and Licensing Agreements
Price: $3.00
*
EvoGenix granted U.S. patent covering Evibodies
2007 FEB 26 ... Antibody therapeutics company EvoGenix Ltd (EGX) announced that it has been awarded a patent by the U.S. Patent Office (patent ...
Subject: Patents
Price: $3.00
*
EvoGenix describe recent developments
2007 FEB 20 ... news developments at EvoGenix. Report 1: Antibody therapeutics company EvoGenix Ltd (EGX) announced that the U.S. National Institutes of Health (NIH) has selected the ...
Subject: EvoGenix
Price: $3.00
*
Officials from EvoGenix recently report on new developments
2007 JAN 31 ... news developments at EvoGenix. Report 1: Antibody therapeutics company EvoGenix Ltd (EGX) announced that the U.S. National Institutes of Health (NIH) has selected the ...
Subject: EvoGenix
Price: $3.00
*
Recent studies from EvoGenix Limited add new data to immunology
2007 JAN 9 ... against incorrectly produced protein variants," wrote G. Kopsidas and colleagues, EvoGenix Limited. The researchers concluded: "Interestingly, a further mutation ...
Subject: Immunology
Price: $3.00
*
EvoGenix officials provide details on the latest developments
2006 DEC 25 ... EvoGenix officials provide details on the latest developments. This trend article ...
Subject: EvoGenix
Price: $3.00
*
EvoGenix to collaborate with U.S. National Institutes of Health
2006 DEC 4 ... Antibody therapeutics company EvoGenix Ltd (EGX) announced that the U.S. National Institutes of Health (NIH) has selected the ...
Subject: Collaborations
Price: $3.00
*
EvoGenix completes project with GlaxoSmithKline
2006 NOV 20 ... EvoGenix Limited reported that it had completed the first project in its collaboration with ...
Subject: Business Update
Price: $3.00
*
Recent findings from InNexus Biotechnology provide an update on new developments
2006 NOV 13 ... viral infections. InNexus will work with antibody therapeutic company EvoGenix, Ltd., (EGX), which is developing an improved version of the antiviral drug for clinical ...
Subject: InNexus Biotechnology
Price: $3.00
*
InNexus announces collaboration focused on developing novel antiviral antibodies
2006 OCT 30 ... viral infections. InNexus will work with antibody therapeutic company EvoGenix, Ltd., (EGX), which is developing an improved version of the antiviral drug for clinical ...
Subject: Collaborations
Price: $3.00
*
EvoGenix offered $1.6 million grant for cancer drug program
2006 AUG 7 ... Antibody therapeutics company EvoGenix Limited (EGX) announced that it had been offered a grant of $1.66 million to fast track ...
Subject: Finance
Price: $3.00
*
EvoGenix announces antibody collaboration with CSL
2006 JUN 26 ... Antibody therapeutics company EvoGenix Limited announced that it had entered into a technology collaboration agreement with CSL ...
Subject: Collaborations
Price: $3.00
*
EvoGenix in-licenses cancer antibody
2006 MAY 8 ... Antibody therapeutics company EvoGenix Limited (EGX) announced the in-licensing of an anti-cancer antibody discovered by ...
Subject: Cancer Research
Price: $3.00
*
Researchers develop lung cancer antibody that leaves normal cells untouched
2006 MAY 1 ... company based in Sydney Australia, with offices in Mountain View, California. EvoGenix has licensed the rights to DMF 10 and Dr. Rock will join the company's scientific ...
Subject: Lung Cancer
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login